9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.

All-trans retinoic acid (tRA) inhibits growth of estrogen receptor-positive (ER+) breast cancer cells in vitro, and a variety of retinoids inhibit development of breast cancer in animal models. 9-cis retinoic acid (9-cis RA) is a naturally occurring high affinity ligand for the retinoid X receptors, as well as the retinoic acid receptors (RARs). Whether 9-cis RA has a different spectrum of biological activity from tRA, which only binds RARs with high affinity, is largely unknown. We studied the effects of 9-cis RA on growth and gene expression in ER+ and ER- human breast cancer cells. 9-cis RA inhibited the growth in monolayer culture of several ER+, but not ER-, cell lines in a dose-dependent manner. Growth inhibition and morphological changes by 9-cis RA were similar to those of tRA, suggesting that the ability to bind both RAR and retinoid X receptors did not significantly augment growth inhibition or confer sensitivity to tRA-resistant lines. MCF-7 cells exposed to 9-cis RA showed a dose-dependent accumulation in G1. Northern analyses showed that RAR-alpha and RAR-beta were not significantly regulated, while RAR-gamma was up-regulated and retinoid X receptor alpha was down-regulated by 9-cis RA. Since interactions between tRA and ER-dependent transcription have recently been reported, we investigated whether these retinoids regulate expression of ER itself or estrogen-responsive genes. Both 9-cis RA and tRA induce down-regulation of ER mRNA and protein in MCF-7 cells. 9-cis RA down-regulates expression of the estrogen-responsive genes PR and pS2 in MCF-7 cells as reported previously for tRA. In several ER-positive subclones, we found that the degree of ER expression and regulation, but not always estrogen-sensitivity, correlates with the growth-inhibitory effects of 9-cis RA. Further, in an ER-, retinoid-unresponsive breast cancer cell line, induced ER expression confers responsiveness to retinoid growth inhibition. These data, combined with reports of additive growth inhibition of tRA and tamoxifen in vitro, suggest that 9-cis RA might augment the ability of tamoxifen to inhibit growth of ER+ breast cancer cells in vivo.

[1]  R. Lotan.  Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. , 1979, Cancer research.

[2]  K J Cullen,et al.  Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. , 1992, Molecular endocrinology.

[3]  P. Chambon,et al.  PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. , 1993, The EMBO journal.

[4]  L. Goldsmith,et al.  Transcriptional control of epidermal growth factor receptor by retinoic acid. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[5]  J. Fontana,et al.  Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7. , 1992, Cancer research.

[6]  M. Lippman,et al.  Binding of retinoids to human breast cancer cell lines and their effects on cell growth. , 1980, The Journal of clinical investigation.

[7]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[8]  J. Manson,et al.  A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. , 1993, The New England journal of medicine.

[9]  N. Gas,et al.  Effects of differentiation‐inducing agents on maturation of human MCF‐7 breast cancer cells , 1990, Journal of cellular physiology.

[10]  D. Leroith,et al.  Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation. , 1991, Endocrinology.

[11]  C. Clarke,et al.  Expression and regulation of retinoic acid receptors in human breast cancer cells. , 1992, Cancer research.

[12]  J. Lehmann,et al.  RAR gamma 2 expression is regulated through a retinoic acid response element embedded in Sp1 sites , 1992, Molecular and cellular biology.

[13]  B. Burg,et al.  Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function , 1993, Molecular and Cellular Endocrinology.

[14]  J. Graham,et al.  Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. , 1990, The Journal of biological chemistry.

[15]  Pierre Chambon,et al.  A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.

[16]  R. Sager,et al.  Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. , 1993, Cancer research.

[17]  Z. Shao,et al.  Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells. , 1992, Cancer research.

[18]  W. Bollag,et al.  Retinoids in cancer prevention and therapy. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  M. Sporn,et al.  The Retinoids : biology, chemistry, and medicine , 1994 .

[20]  H. Scher,et al.  Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[21]  M. Sporn,et al.  N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. , 1979, Cancer research.

[22]  R. Schwartz,et al.  Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. , 1983, Biochemistry.

[23]  J. Fontana.  Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. , 1987, Experimental cell biology.

[24]  J. Grippo,et al.  9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.

[25]  E. Dmitrovsky,et al.  9-cis and all-trans retinoic acid induce a similar phenotype in human teratocarcinoma cells. , 1993, Differentiation; research in biological diversity.

[26]  E. Dmitrovsky,et al.  Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line. , 1990, Oncogene.

[27]  J. Nicolas,et al.  Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. , 1994, Cancer research.

[28]  S. Hirschfeld,et al.  Inhibition of estrogen-responsive gene activation by the retinoid X receptor beta: evidence for multiple inhibitory pathways , 1993, Molecular and cellular biology.

[29]  P. Balaguer,et al.  Study of an antiestrogenic effect of retinoic acid in MCF-7 cells. , 1992, Biochemical and biophysical research communications.

[30]  V. Jordan,et al.  Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. , 1992, Journal of the National Cancer Institute.

[31]  P. Chambon,et al.  A third human retinoic acid receptor , hRAR-y ( skin / nuclear receptors / vitamin A / transcriptional activation ) , 2022 .

[32]  R. Sutherland,et al.  Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast‐cancer cells , 1992, International journal of cancer.